VANCOUVER, Feb. 10, 2017 /PRNewswire/ - Alternate
Health Corp. (CSE:AHG) (the "Company") is
pleased to announce recent appointments to the Company's Board of
Directors and Officers of the Company. The following Directors and
Officers have been appointed:
Bryan Korba – Chairman and
Chief Executive Officer
Bryan has spent the last 17 years as
the Managing Partner of JDIFU Capital, a consulting and private
equity investment company he co-founded with his late father and
mentor, Robert Korba. The company
manages the assets and private equity investments of the Korba
Family Investment Office. JDFIU Capital has completed over
$100 million in investments in varied
industries including healthcare, real estate, software,
franchising, hospitality, furniture and financial services.
Additionally, Bryan has consulted with many CEOs on mergers and
acquisitions, strategic planning, corporate development and company
culture and governance. Bryan currently serves on the board of
Empower Heroes, a charity he co-founded that services veterans and
their families as they re-enter civilian life. Bryan previously
served on the boards of 36 Power Equity, Luxe Home, Dallas
Challenge and the UNT Venture Fund. Bryan earned a MBA in finance
from Texas Christian University and a
BBA in economics from the University of North
Texas and continues to guest lecture on real estate and
entrepreneurial ventures.
Michael English – Chief
Financial Officer
Mike
English has over 30 years' experience working in diverse
industries including data security and encryption software,
telecommunications, and heavy industrial electric motors and
controls. Ten of those years were with a leading software as
a service (SAAS) public encryption company where he served as
controller and CFO. Under Mike's leadership, the company
drastically improved earnings and cash flow while reducing the
company's risk profile and improving compliance. They
achieved best in class public company audit committee ISS
governance ratings. As a Vice President of Finance and
Controller in the telecommunications and heavy industrial electric
motors and controls industries, Mike managed large groups including
director level direct reports in multi-locations, both domestic and
international (US, Canada, UK,
Germany, Italy and Israel). In addition to accounting and
reporting responsibilities, a major part of his role included
implementing and integrating enterprise wide software (SAP) across
several manufacturing divisions. Over a career that spans
auditing, controllership, financial systems and senior executive
financial management, Mike's experience reaches across technical
accounting, financial reporting and disclosure controls, risk
avoidance, multi-location, SEC reporting, public company corporate
governance, equity compensation, manufacturing cost accounting and
includes HR and benefits, IT, facilities management and
strategy. Mike earned a BA in English with a concentration in
business from John Carroll University
and an MS in Accountancy from DePaul University. He is a CPA
and is a member of the Ohio Society of CPA's.
Thomas Bartlett – Chief
Operating Officer
Tom
Bartlett has over thirty years of private equity, investment
banking, corporate advisory, and operating experience.
Throughout his career, Tom has financed, advised or served in
executive management capacities to drive growth and value
appreciation of businesses operating across a spectrum of
industries and business models. Prior to joining Alternate
Health Corp. as its Chief Operating Officer, Tom served as the
President and CFO of an insurance services company where Tom was
directly responsible for executing multiple acquisitions and
financings for the business in addition to overseeing the overall
operational and financial functions of the company. In his
capacity of COO at Alternate Health, Tom is primarily responsible
for implementing and directing growth and diversification
strategies across the AHC platform. Tom has a BBA in finance
and management from Baylor
University.
Jamison Feramisco –
Director
Dr. Jamison
Feramisco, MD, PhD, is trained in both Internal Medicine and
Dermatology and completed his PhD research thesis in the laboratory
of Nobel Laureates Drs. Mike Brown
and Joe Goldstein at UT Southwestern
Medical Center. He has an extensive history of success in
founding, funding, and growing numerous healthcare service and
technology companies. Dr. Feramisco is the founder and
President of Apri Health (formerly Transfuse Solutions), a
next-generation healthcare data analytics and change management
company based in Dallas,
Texas. He also serves as Chief Medical Officer of both
Third Eye Health, a technology-enabled medical services company,
and Advanced Healthcare Solutions nursing home chain. His
former positions include founder and President of Golden Healthcare
of Temecula, California, a medical
service corporation specializing in home health care designed with
the patient's need for personal care and safety in mind; Chief
Medical Officer of Scanadu, a cutting edge wearable device company
with headquarters at NASA's Moffitt Field, CA.; co-founder and
chief medical officer/chief operating officer of Dermlink, one of
the first consumer focused tele-dermatology software
companies. He has served on the board of multiple healthcare
and technology companies and is an active mentor at many of the Bay
Area healthcare incubators. Clinically, Dr. Feramisco focuses
primarily on three areas of medicine: 1) Hospitalist Medicine -
general medical care of hospitalized patients including patient
care, teaching, research and leadership related to hospital
medicine; 2) Dermatology, the medical care of the skin and its
diseases; and 3) Wound Care, the medical care in the prevention of
wound complications and the promotion of wound healing. Dr.
Feramisco has a successful track record as an entrepreneur and is a
respected Angel Investor and consultant for venture capital and
private equity.
Adam Desmond -
Director
Adam Desmond began
his career at the Chicago Mercantile Exchange in the financial
quadrant. He then went on to Raymond
James and Associates where he helped develop a high yield
fixed income department. This experience gave him the groundwork to
found ASG Securities in 1998. There, his vision was to focus
exclusively on small/mid-cap banks and thrift markets. In 2004, ASG
Securities transformed into FIG Partners LLC. As Founder and one of
the Managing Principals, Adam and his team added a research
division to expand the business from a sales and trading platform
into a full service investment banking firm. This implementation
resulted in full research on over 120 banks. Under his leadership,
as co-head of Investment Banking, Adam assembled a team of
principals at raised more than $2.5
billion in equity since 2007 and completed more than 95
whole bank transactions throughout the
United States. Through the trading platform Fig was a market
maker in over 800 community banks and thrifts. As Fig's reputation
grew, Adam directed the strategy to create both Fixed Income and
Corporate Development departments to implement cross selling to
Fig's client base. With its headquarters in Atlanta, FIG Partners expanded from one office
and a hand full of employees, to offices in Chicago, Los
Angeles, San Francisco,
Dallas, New Jersey and Charlotte, employing over 60
people. Adam's expertise in the banking sector has brought him into
contact with top executives from over 250 banks and thrifts, as
well as building close relationships with the foremost
institutional equity managers. He also served as a board member for
Goldwater Bank in Scottsdale
Arizona. Adam recently created Needle Rock Capital to
leverage his past expertise in the financial industry and his
relationships. In addition, he founded Needle Rock Farms, to
explore alternative health solutions. Adam prides himself on being
a member of the Elks Club. He enjoys supporting and servicing
many charitable organizations. For example, Adam sponsored
charitable organizations in India
and Laos. Through St. Mary's
Catholic Church in Aspen, he
helped fund the building of a school in the Philippines. Adam graduated from the
University of Wisconsin – Madison with
a Bachelor of Arts in International Economics and Political
Science.
Marcelin O'Neill – Corporate Secretary and Compliance
Officer
Marcelin O'Neill is
currently a Director and CEO of Cervantes Capital Corp., and also
presently the Compliance Officer and Corporate Secretary of
Alternate Health Corp. Ms. O'Neill served as a Director of Jagercor
Energy Corp. from December 2011 to
May 2014, and as Chief Financial
Officer and Corporate Secretary of Jagercor, from July 2013 to May
2014. She served as a director of Brandenburg Energy Corp.
from February 2008 to February 2013, and as Chief Financial Officer and
Corporate Secretary from August 2010
to February 2013. Ms. O'Neill served
as the Vice President of Corporate Affairs of Mandalay Resources
Corporation from April 2009 to
March 2010, and from April 2007 until May
2008, she served as a director of Mandalay. Since 1994 Ms.
O'Neill has worked with such companies as Augusta Resource
Corporation, Westcoast Energy Inc., and the Lundin Group. In 1987,
Ms. O'Neill graduated from the British Columbia Institute of
Technology, where she studied Business Management, and has
successfully completed the CSC and the CPH, both with honors. Ms.
O'Neill is the managing director of Accrete Consulting Inc., a
company which provides corporate governance and management services
to public companies. With over 23 years of experience in public
company management, Ms. O'Neill brings a varied scope of knowledge
to the companies with which she works.
Resignations
The Company wishes to announce that the
following individuals have tendered their resignations to the
respective roles as indicated: Marjorie
Sanderson resigned as Director and Chief Executive Officer,
Jim Griffiths resigned as Chief
Financial Officer, Marcelin O'Neill
resigned as a Director of the Company; and Rick Macartney resigned as a Director of the
Company. Alternate Health would like to thank Ms. Sanderson,
Mr. Griffiths, Ms. O'Neill, and Mr. Macartney for their assistance
while serving in the aforementioned roles.
The Board of Directors is now comprised of Bryan Korba, Jim
Tykoliz, Jim Griffiths,
Jamison Feramisco and Adam Desmond.
"This is the right time for Bryan and his incoming team to lead
Alternate Health into the next chapter of our company's exciting
future. Bryan brings a unique combination of entrepreneurial
experiences with a dedication to creating and executing dynamic
strategic plans. His vision, strategy and execution track record is
exactly what Alternate Health needs at this point of rapid growth
and market expansion. I am confident in the strong leadership that
Bryan will bring to our company and know he will energize and
inspire our employees, shareholders, customers and partners," said
Alternate Health Director Jim
Griffiths.
About Alternate Health
Alternate Health (http://www.alternatehealth.ca) is a
diversified healthcare company that uses its expertise in
technology to revolutionize patient care and service delivery in
both traditional and complementary medical fields. With
investments in research, education and cutting edge technology,
Alternate Health is a leader in software applications and
processing systems for the medical industry using proprietary
technology platforms. Through its subsidiaries, Alternate
Health offers services ranging from medical practice and controlled
substance management software to blood analysis and toxicology
labs, to clinical research and continuing education programs.
Alternate Health's goal is to continue to lead the medical industry
with data-driven results in patient care and product
development.
On behalf of the Board of Directors of
ALTERNATE HEALTH CORP.
"Bryan Korba"
Chairman
and CEO
Neither the CSE nor its Regulation Services Provider (as that
term is defined in the policies of the CSE) accepts
responsibility for the adequacy or accuracy of this
release.
Statements included in this announcement, including
statements concerning our plans, intentions and expectations, which
are not historical in nature are intended to be, and are hereby
identified as "forward-looking statements". Forward-looking
statements may be identified by words including "anticipates",
"believes", "intends", "estimates", "expects" and similar
expressions. The Company cautions readers that
forward-looking statements, including without limitation those
relating to the Company's future operations, business prospects and
financing plans, are subject to certain risks and uncertainties
that could cause actual results to differ materially from those
indicated in the forward- looking statements.
SOURCE Alternate Health Corp.